scholarly journals Structural Analysis and Epitope Prediction of MHC Class-1-Chain Related Protein-A for Cancer Vaccine Development

Vaccines ◽  
2017 ◽  
Vol 6 (1) ◽  
pp. 1 ◽  
Author(s):  
Tayo Adekiya ◽  
Raphael Aruleba ◽  
Sbonelo Khanyile ◽  
Priscilla Masamba ◽  
Babatunji Oyinloye ◽  
...  
2012 ◽  
Vol 19 (4) ◽  
pp. 477-489 ◽  
Author(s):  
Paulraj K. Lawrence ◽  
Bachra Rokbi ◽  
Nadège Arnaud-Barbe ◽  
Eric L. Sutten ◽  
Junzo Norimine ◽  
...  

ABSTRACTStaphylococcus aureusis a commensal bacterium associated with the skin and mucosal surfaces of humans and animals that can also cause chronic infection. The emergence of antibiotic-resistant strains such as methicillin-resistantS. aureus(MRSA) and strains causing chronic intramammary infections (IMI) in cows results in severe human and livestock infections. Conventional approaches to vaccine development have yielded only a few noneffective vaccines against MRSA or IMI strains, so there is a need for improved vaccine development. CD4 T lymphocytes are required for promoting gamma interferon (IFN-γ) mediated immunoglobulin isotype switching in B lymphocytes to produce high-affinity IgG antibodies and IFN-γ-mediated phagocyte activation for an effective resolution of bacterial infection. However, the lack of known CD4 T cell antigens fromS. aureushas made it difficult to design effective vaccines. The goal of this study was to identifyS. aureusproteins recognized by immune CD4 T cells. Using a reverse genetics approach, 43 antigens were selected from theS. aureusNewman strain. These included lipoproteins, proteases, transcription regulators, an alkaline shock protein, conserved-domain proteins, hemolysins, fibrinogen-binding protein, staphylokinase, exotoxin, enterotoxin, sortase, and protein A. Screening of expressed proteins for recall T cell responses in outbred, immune calves identified 13 proteins that share over 80% sequence identity among MRSA or IMI strains. These may be useful for inclusion in a broadly protective multiantigen vaccine against MRSA or IMI.


1998 ◽  
Vol 331 (3) ◽  
pp. 947-952 ◽  
Author(s):  
Jefferson W. LOOMIS-HUSSELBEE ◽  
Christopher D. WALKER ◽  
Joanna R. BOTTOMLEY ◽  
Peter J. CULLEN ◽  
Robin F. IRVINE ◽  
...  

We have previously shown that addition of Ins(1,3,4,5)P4 to permeabilized L1210 cells increases the amount of Ca2+ mobilized by a submaximal concentration of Ins(2,4,5)P3, and we suggested that, in doing this, Ins(1,3,4,5)P4 is not working via an InsP3 receptor but indirectly via an InsP4 receptor [Loomis-Husselbee, Cullen, Dreikhausen, Irvine and Dawson (1996) Biochem. J. 314, 811–816]. Here we have investigated whether this effect might be mediated by GAP1IP4BP, recently identified as a putative receptor for Ins(1,3,4,5)P4. GAP1IP4BP is a protein that interacts with one or more monomeric G-proteins, so we sought evidence for involvement of monomeric G-proteins in the effects of Ins(1,3,4,5)P4 in permeabilized L1210 cells. Guanosine 5´-[γ-thio]triphosphate (GTP[S]) enhanced the effect of Ins(1,3,4,5)P4 on Ins(2,4,5)P3-stimulated Ca2+ mobilization, but had no effect on the action of Ins(2,4,5)P3 alone. A specific enhancement of only the action of Ins(1,3,4,5)P4 was also seen with GTP[S]-loaded R-Ras or Rap1a (two G-proteins known to interact with GAP1IP4BP), whereas H-Ras was inactive at similar concentrations. Guanosine 5´-[β-thio]diphosphate (GDP[S]) did not alter the action of either Ins(2,4,5)P3 or Ins(1,3,4,5)P4. Finally, the addition of exogenous GAP1IP4BP, purified from platelets, markedly enhanced the effect of Ins(1,3,4,5)P4, and again, the amount of Ca2+ mobilized by Ins(2,4,5)P3 alone was unaltered. We conclude that the increase in Ins(2,4,5)P3-stimulated Ca2+ mobilization by Ins(1,3,4,5)P4 may be mediated by GAP1IP4BP or a closely related protein (such as GAP1m), and if so, the action of the GAP1 is not solely to regulate GTP loading of a G-protein, but rather it acts with a G-protein to cause its effect.


Nanoscale ◽  
2017 ◽  
Vol 9 (37) ◽  
pp. 14058-14064 ◽  
Author(s):  
Zhongyan Wang ◽  
Chunhui Liang ◽  
Fang Shi ◽  
Tao He ◽  
Changyang Gong ◽  
...  

We demonstrated in this study that supramolecular hydrogels of NSAID-modified peptides are promising adjuvants for cancer vaccine development.


Endocrine ◽  
2012 ◽  
Vol 42 (2) ◽  
pp. 436-441
Author(s):  
Robert R. Kraemer ◽  
V. Daniel Castracane ◽  
Michelle Francois ◽  
Abbass Ghanbari-Niaki ◽  
Bovorn Sirikul ◽  
...  

Sexual Health ◽  
2010 ◽  
Vol 7 (3) ◽  
pp. 230 ◽  
Author(s):  
Ian H. Frazer

Cervical cancer is initiated by infection of cervical epithelium with human papillomavirus. Vaccines have been developed, incorporating papillomavirus viral capsids and alum based adjuvants. In extensive clinical trials these vaccines have been shown safe and effective in preventing infection with, and disease caused by, the papillomavirus genotypes they incorporate, in women not already infected. These vaccines have the potential to reduce the global burden of cervical cancer by up to 70%.


Sign in / Sign up

Export Citation Format

Share Document